Literature DB >> 28441273

Case Report of Physiologic Phenibut Dependence Treated With a Phenobarbital Taper in a Patient Being Treated With Buprenorphine.

Emily Brunner1, Robert Levy.   

Abstract

: This case report describes the development of dependence to phenibut, a gamma-aminobutyric acid-receptor type B agonist, in a patient concurrently being treated with buprenorphine. The patient experienced withdrawal symptoms which were successfully treated with a phenobarbital taper based on a protocol to treat sedative use disorder. This case report provided an example of the development of a phenibut use disorder and also brought up a public health question of whether phenibut should therefore be officially classified and monitored.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28441273     DOI: 10.1097/ADM.0000000000000303

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  5 in total

Review 1.  Acute phenibut withdrawal: A comprehensive literature review and illustrative case report.

Authors:  Matthew I Hardman; Juraj Sprung; Toby N Weingarten
Journal:  Bosn J Basic Med Sci       Date:  2019-05-20       Impact factor: 3.363

Review 2.  Phenibut (β-Phenyl-γ-Aminobutyric Acid): an Easily Obtainable "Dietary Supplement" With Propensities for Physical Dependence and Addiction.

Authors:  Edward A Jouney
Journal:  Curr Psychiatry Rep       Date:  2019-03-09       Impact factor: 5.285

3.  The Psychonauts' World of Cognitive Enhancers.

Authors:  Flavia Napoletano; Fabrizio Schifano; John Martin Corkery; Amira Guirguis; Davide Arillotta; Caroline Zangani; Alessandro Vento
Journal:  Front Psychiatry       Date:  2020-09-11       Impact factor: 4.157

4.  Phenibut (β-Phenyl-γ-aminobutyric Acid) Dependence and Management of Withdrawal: Emerging Nootropics of Abuse.

Authors:  Tania Ahuja; Ofole Mgbako; Caroline Katzman; Allison Grossman
Journal:  Case Rep Psychiatry       Date:  2018-04-30

5.  Phenibut Addiction in a Patient with Substance Use Disorder.

Authors:  Kan Hong Zheng; Afra Khan; Eduardo D Espiridion
Journal:  Cureus       Date:  2019-07-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.